Gert Storm Selected Research

dexamethasone 21-phosphate

1/2019	Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma.
11/2012	Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.
4/2006	Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gert Storm Research Topics

Disease

142	Neoplasms (Cancer) 01/2022 - 02/2002
35	Inflammation (Inflammations) 01/2022 - 01/2002
15	Arthritis (Polyarthritis) 01/2018 - 01/2002
13	Experimental Arthritis 01/2018 - 08/2002
12	Fibrosis (Cirrhosis) 01/2021 - 01/2012
11	Hyperthermia 06/2020 - 02/2007
11	Carcinoma (Carcinomatosis) 01/2018 - 07/2002
9	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 01/2015
9	Rheumatoid Arthritis 06/2016 - 01/2005
9	Melanoma (Melanoma, Malignant) 11/2015 - 02/2005
8	Hypersensitivity (Allergy) 01/2022 - 05/2013
8	Atherosclerosis 01/2020 - 12/2010
7	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2012
5	Liver Diseases (Liver Disease) 12/2020 - 01/2015
5	Experimental Melanoma 01/2019 - 06/2006
5	Lung Neoplasms (Lung Cancer) 11/2018 - 12/2010
5	Atherosclerotic Plaque (Atheroma) 01/2016 - 12/2010
4	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2017
4	Disease Progression 01/2021 - 05/2006
4	Multiple Myeloma 10/2020 - 11/2010
4	Necrosis 01/2020 - 08/2003
4	Infections 01/2020 - 02/2002
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2014
3	Thrombosis (Thrombus) 06/2020 - 10/2018
3	Hypoxia (Hypoxemia) 06/2019 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 03/2008 - 02/2002
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2011

Drug/Important Bio-Agent (IBA)

84	Liposomes (Liposome)IBA 01/2022 - 01/2002
60	Pharmaceutical PreparationsIBA 10/2021 - 02/2002
20	GlucocorticoidsIBA 01/2019 - 01/2002
17	prednisolone phosphate FDA LinkGeneric 01/2022 - 07/2003
17	PolymersIBA 06/2020 - 11/2003
16	AntigensIBA 01/2022 - 01/2005
15	MicellesIBA 01/2021 - 10/2010
13	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 08/2003
11	LigandsIBA 06/2020 - 11/2004
10	Small Interfering RNA (siRNA)IBA 10/2021 - 11/2004
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
10	Prednisolone (Predate)FDA LinkGeneric 12/2016 - 08/2003
9	Peptides (Polypeptides)IBA 01/2021 - 10/2004
9	Drug CarriersIBA 01/2019 - 02/2002
9	ErbB Receptors (EGF Receptor)IBA 10/2013 - 07/2002
8	Therapeutic UsesIBA 01/2018 - 01/2003
6	hydroxypropyl methacrylateIBA 01/2013 - 12/2005
5	ProdrugsIBA 01/2022 - 03/2003
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2014
5	methacrylamideIBA 10/2018 - 03/2008
5	IntegrinsIBA 01/2018 - 11/2004
5	liposomal doxorubicin (Doxil)FDA Link 05/2014 - 08/2003
5	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2008 - 07/2003
4	Complement System Proteins (Complement)IBA 01/2022 - 12/2014
4	SteroidsIBA 01/2022 - 09/2011
4	Docetaxel (Taxotere)FDA Link 06/2021 - 01/2016
4	Lactic Acid (Lactate)FDA LinkGeneric 12/2020 - 10/2010
4	Gemcitabine FDA Link 01/2020 - 07/2009
4	CollagenIBA 11/2018 - 08/2012
4	Phosphates (Orthophosphate)IBA 01/2018 - 09/2006
4	Contrast MediaIBA 03/2017 - 12/2005
4	MicroRNAs (MicroRNA)IBA 12/2016 - 08/2014
4	monomethoxypolyethylene glycol (MPEG)IBA 01/2015 - 10/2010
4	RhodaminesIBA 02/2012 - 04/2011
4	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 12/2005
3	GlucuronidaseIBA 01/2022 - 03/2003
3	VaccinesIBA 01/2022 - 10/2013
3	AntibodiesIBA 01/2022 - 07/2012
3	EnzymesIBA 01/2022 - 03/2003
3	Biological ProductsIBA 10/2021 - 06/2011
3	Transferrin (beta 2 Transferrin)IBA 10/2021 - 01/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2020 - 01/2015
3	Phosphotransferases (Kinase)IBA 03/2020 - 04/2012
3	LipidsIBA 01/2020 - 04/2011
3	CytokinesIBA 10/2019 - 01/2002
3	dexamethasone 21-phosphate FDA LinkGeneric 01/2019 - 04/2006
3	CholesterolIBA 09/2018 - 11/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 12/2010
3	Apolipoproteins E (ApoE)IBA 09/2017 - 04/2015
3	ApolipoproteinsIBA 09/2017 - 04/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2004
3	Oxygen (Dioxygen)IBA 09/2014 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 05/2014 - 11/2010
3	arginyl-glycyl-aspartic acidIBA 02/2014 - 11/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 08/2003
3	Ethylene Glycol (Monoethylene Glycol)IBA 07/2011 - 10/2010
3	Monoclonal AntibodiesIBA 07/2010 - 03/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Ophthalmic Solutions (Eye Drops)IBA 01/2022 - 12/2021
2	IodineIBA 12/2021 - 01/2019

Therapy/Procedure

60	Therapeutics 01/2022 - 07/2003
12	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
11	Intravenous Administration 10/2019 - 07/2003
6	Intravenous Injections 01/2020 - 10/2006
6	Radiotherapy 06/2019 - 02/2007
5	Microbubbles 10/2021 - 10/2012
5	Immunotherapy 07/2020 - 11/2010
5	Injections 11/2018 - 07/2003
4	Lasers (Laser) 01/2022 - 02/2012
4	Precision Medicine 01/2019 - 06/2011
3	Aftercare (After-Treatment) 01/2017 - 07/2003